PharVision Advisers’s Unisys UIS Stock Holding History

PharVision Advisers’s Portfolio UIS Stock Details UIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-134,338	Closed	-$371K	–	619
2025 Q4	$371K	Buy	134,338 +124,283	+1,236%	+$388K	0.19%	151
2025 Q3	$39.2K	Buy	+10,055	New	+$40.8K	0.02%	654
2025 Q1	–	Sell	-32,097	Closed	-$203K	–	520
2024 Q4	$203K	Buy	+32,097	New	+$224K	0.17%	296

Other funds holding UIS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

IES Holdings Houston, Texas $214M AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PharVision Advisers's UIS Position: Q1 2026 in Review

PharVision Advisers sold out of Unisys (UIS) in Q1 2026, closing a stake of 134,338 shares — an estimated $371K sold.

PharVision Advisers first reported a position in UIS in Q4 2024 and held it in 3 quarters. The position peaked at $371K in Q4 2025. 154 funds tracked by Wall St. Rank hold UIS as of Q1 2026.

PharVision Advisers reported no remaining Unisys position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 134,338 Unisys shares in Q1 2026, an estimated $371K.
PharVision Advisers first reported a position in Unisys in Q4 2024 and held it in 3 quarters.
PharVision Advisers's Unisys position peaked at $371K in Q4 2025.
154 funds tracked by Wall St. Rank held Unisys as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.